Latest Articles

Publication Date
Diagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights.

Endometriosis is a common gynecological condition affecting approximately 10% of women of reproductive age, characterized by the abnormal presence of endometrial-like tissue outside the uterus. Although endometriosis was first described …

Published: Dec. 17, 2024, midnight
Kisspeptin and Endometriosis-Is There a Link?

This article presents a narrative review that explores the potential link between kisspeptin-a key regulator of the hypothalamic-pituitary-gonadal axis-and the pathogenesis of endometriosis. Kisspeptin plays a significant role in regulating …

Published: Dec. 17, 2024, midnight
First use of cord blood platelet-rich plasma in the treatment of vulvar lichen sclerosus: a preliminary study towards a randomized controlled trial.

Although topical corticosteroids (TCS) represent first-line treatment for vulvar lichen sclerosus (VLS) and as such should be prescribed to all women at time of diagnosis, approximately 30% of patients do …

Published: Dec. 17, 2024, midnight
Endometrioid adenocarcinoma of the colon arising from rare malignant transformation of extra-gonadal endometrioma.

Endometriosis is a common condition with a rare malignant potential. We report a case of a patient with a colon mass who underwent surgery for malignant endometriosis associated cancer.Case: A …

Published: Dec. 17, 2024, midnight
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study.

Several reproductive factors are associated with ovarian cancer risk but the association with survival is less clear. The main aim was to examine the impact of pre-diagnostic reproductive factors on …

Published: Dec. 17, 2024, midnight
GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer - TipRanks

GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer TipRanks

Published: Dec. 16, 2024, 7:45 a.m.
Proteomics $2.16m R&D rebate fuels breakthrough blood tests - MSN

Proteomics $2.16m R&D rebate fuels breakthrough blood tests MSN

Published: Dec. 16, 2024, 4:40 a.m.
Proteomics $2.16m R&D rebate fuels breakthrough blood tests - Brisbane Times

Proteomics $2.16m R&D rebate fuels breakthrough blood tests Brisbane Times

Published: Dec. 16, 2024, 4:17 a.m.
Proteomics $2.16m R&D rebate fuels breakthrough blood tests - The Age

Proteomics $2.16m R&D rebate fuels breakthrough blood tests The Age

Published: Dec. 16, 2024, 4:17 a.m.
Differential characteristics of vaginal versus endometrial microbiota in IVF patients.

Abnormal female reproductive tract microbiota are associated with gynecological disorders such as endometriosis or chronic endometritis and may affect reproductive outcomes. However, the differential diagnostic utility of the vaginal or …

Published: Dec. 16, 2024, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!